Clinical trial Recruiting at 1 site Interventional Ages 8 and up Women only

ActiveGirls physical activity program for hormone health and diabetes-risk prevention in girls ages 8–12

Official title: ActiveGirls: Physical Activity, Hormone Health, and Diabetes Risk in Early Adolescence

Run by Massachusetts General Hospital · NCT07102797 · Data updated 2026-11-12

This study will test whether a 6-month ActiveGirls program with coaching and messages helps girls ages 8–12 improve hormone health and lower markers of diabetes risk compared with a lower-intensity, delayed program.

Quick facts

Study typeInterventional
Ages8 Years and up
SexWomen only
Enrollment40 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Somerville, Massachusetts)
StatusRecruiting
StartedNovember 24, 2025
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedMarch 19, 2026
Trial IDNCT07102797 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Girls ages 8–12 who are premenarchal and at increased risk for PCOS or insulin resistance (for example due to BMI ≥85th percentile, maternal PCOS/GDM, premature adrenarche, or being small for gestational age) and who have a caregiver able to participate are ideal candidates.

Probably not a fit

Girls who are post-menarche, have diagnosed type 1 or type 2 diabetes, other endocrine conditions that affect insulin or androgens, or who are taking medications such as metformin, GLP-1 receptor agonists, insulin, or GnRH agonists are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a pilot randomized trial enrolling premenarchal girls ages 8–12 who are at elevated risk for PCOS or insulin resistance. Participants are randomized to a full-intensity intervention with health coaching plus educational texts/emails or a delayed, lower-intensity text-only intervention, with caregiver involvement to support at-home activity. Both groups complete objective measures of body composition, insulin dynamics, reproductive hormones, fitness, and continuous activity monitoring, plus surveys at baseline, 6 months, and 12 months. Baseline and 12-month visits are in person at the MGH Translational and Clinical Research Centers and the 6-month assessment is remote.

Why it matters

Potential benefit: If successful, the program could help at-risk girls increase physical activity, improve hormone balance, and reduce early markers of diabetes risk.

How similar studies have gone: Some family-based lifestyle and physical activity programs have improved weight and metabolic markers in youth, but interventions specifically targeting peripubertal prevention of PCOS and insulin resistance are limited and this pilot is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Caregiver: Caregiver of child (ie mother, father, or other legal guardian), English-speaking, Access to a device where they are able to receive study e-mails or texts
* Child: English-speaking, Female, ages 8-12 years old at time of enrollment, Pre-menarchal at time of baseline visit, at risk for Polycystic Ovary Syndrome (PCOS)/insulin resistance, as defined by (1) History of maternal PCOS/maternal GDM, (2) BMI \>/= 85th percentile, (3) History of premature adrenarche, or (4) Small (\<10th %ile) for gestational age

Exclusion Criteria (Child):

* Medications at time of enrollment: Metformin, GLP-1R Agonist, Insulin, GnRH agonist
* Endocrine conditions that would impact either insulin sensitivity, androgen concentrations, or growth
* Insulin dynamics: Type 1 diabetes, Type 2 diabetes, Congenital Hyperinsulinism
* Androgen Conditions: Adrenal tumor, Congenital Adrenal Hyperplasia
* Hyperthyroidism or uncontrolled hypothyroidism (TSH \>7.0 mIU/mL)
* Growth Hormone Deficiency
* Medical conditions that would impact PA participation: Type 1 diabetes; Cardiovascular, neurologic, and/or musculoskeletal conditions limiting ability to participate in physical activity.
* Other medical comorbidities that would limit generalizability of findings, including: Severe congenital heart disease, Congenital anomalies, Cystic fibrosis, Cerebral palsy, Condition requiring use of nasogastric, gastric tube, or other alternative method of feeding, Undiagnosed conditions with significant impact on child's growth and development; Significant cardiac, hepatic, oncologic, inflammatory, or psychiatric disease.

Where it's running

  • Massachusetts General Hospital
    Somerville, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.